3,057 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Purchased by Peddock Capital Advisors LLC

Peddock Capital Advisors LLC acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,057 shares of the exchange traded fund’s stock, valued at approximately $302,000.

Other institutional investors have also bought and sold shares of the company. Scarborough Advisors LLC bought a new stake in SPDR S&P Biotech ETF in the fourth quarter worth about $32,000. ORG Partners LLC bought a new stake in SPDR S&P Biotech ETF in the second quarter worth about $40,000. Vima LLC purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $45,000. Resources Management Corp CT ADV lifted its stake in SPDR S&P Biotech ETF by 30.3% during the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock valued at $55,000 after buying an additional 138 shares in the last quarter. Finally, SOA Wealth Advisors LLC. lifted its stake in SPDR S&P Biotech ETF by 79.8% during the first quarter. SOA Wealth Advisors LLC. now owns 597 shares of the exchange traded fund’s stock valued at $57,000 after buying an additional 265 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 0.6 %

XBI stock traded down $0.55 during mid-day trading on Wednesday, reaching $96.55. 1,768,535 shares of the stock traded hands, compared to its average volume of 9,566,846. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52. The company has a market cap of $7.36 billion, a P/E ratio of 11.47 and a beta of 1.11. The stock’s fifty day moving average is $98.60 and its 200-day moving average is $94.09.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.